{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:07:04Z","timestamp":1779530824547,"version":"3.53.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Good\u2019s syndrome (GS) is a rare adult-onset immunodeficiency characterized by the coexistence of thymoma and profound defects in both humoral and cellular immunity. Because of these immune abnormalities, patients are highly vulnerable to recurrent and severe infections, such as COVID-19. However, clinical data on the course and management of COVID-19 in GS remain scarce. This case report aims to describe a patient with recurrent severe COVID-19 following thymectomy and to highlight the diagnostic and therapeutic importance of early immunologic evaluation and intravenous immunoglobulin (IVIG) therapy in this context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 60-year-old man with a history of thymoma resection presented with recurrent episodes of severe COVID-19 pneumonia, each necessitating hospitalization and oxygen therapy. Despite antiviral and corticosteroid treatment, his condition worsened, with persistent hypoxemia and progressive lung infiltrates. Immunologic workup revealed near-complete B-cell depletion and reduced CD4\u2005+\u2005T-cell counts, leading to a diagnosis of GS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>GS following thymoma resection, presenting with recurrent severe COVID-19 complicated by bacterial superinfection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient received antiviral agents, corticosteroids, and broad-spectrum antibiotics across multiple hospitalizations. After diagnosis, IVIG therapy was initiated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>IVIG administration led to rapid clinical stabilization and marked radiographic improvement. The patient remained free of relapse during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case highlights the importance of early immunologic assessment in patients with atypical or recurrent viral infections post-thymectomy. Prompt recognition of GS and initiation of IVIG therapy can be critical to achieving favorable outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046198","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:01:24Z","timestamp":1764972084000},"page":"e46198","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent severe COVID-19 with Good\u2019s syndrome in a patient after thymoma surgery: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6558-4790","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Respiratory, Shenyang Tenth People\u2019s Hospital, Shenyang Chest Hospital, Shenyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-7291","authenticated-orcid":false,"given":"Huan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory, Shenyang Tenth People\u2019s Hospital, Shenyang Chest Hospital, Shenyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41380-022-01614-7","article-title":"A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action.","volume":"28","author":"Zeng","year":"2023","journal-title":"Mol Psychiatry"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.jinf.2020.05.017","article-title":"Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis.","volume":"81","author":"Gao","year":"2020","journal-title":"J Infect"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/apm.13351","article-title":"Good\u2019s syndrome: brief overview of an enigmatic immune deficiency.","volume":"131","author":"Sipos","year":"2023","journal-title":"APMIS"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2020.12.010","article-title":"Immunodeficiency and thymoma in Good syndrome: two sides of the same coin.","volume":"231","author":"Guevara-Hoyer","year":"2021","journal-title":"Immunol Lett"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hcs2.36","article-title":"Diagnosis and treatment protocol for COVID\u201019 patients (Tentative 10th Version).","volume":"2","year":"2023","journal-title":"Health Care Sci"},{"key":"R6-20260523","first-page":"5282","article-title":"Expert consensus statement on Xiyanping Injection for respiratory system infectious diseases in clinical practice(adults).","volume":"44","author":"Wang","year":"2019","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13596-023-00702-5","article-title":"Mechanisms and clinical application of Xuebijing injection, a traditional Chinese herbal medicine\u2013a systematic review.","volume":"24","author":"Chen","year":"2024","journal-title":"Adv Tradit Med"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jaip.2023.12.018","article-title":"Unraveling the natural history of Good\u2019s syndrome: a progressive adult combined immunodeficiency.","volume":"12","author":"Kabir","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/icvts\/ivu343","article-title":"Routine thymectomy in congenital cardiac surgery changes adaptive immunity without clinical relevance.","volume":"20","author":"Roosen","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-021-02058-6","article-title":"Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.","volume":"19","author":"Treskova-Schwarzbach","year":"2021","journal-title":"BMC Med"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"864838","DOI":"10.3389\/fimmu.2022.864838","article-title":"Systematic review and meta-analyses of the interaction between HIV infection and COVID-19: two years\u2019 evidence summary.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijid.2022.12.040","article-title":"Relapsing COVID-19 infection as a manifestation of Good syndrome: a case report and literature review.","volume":"129","author":"Wee","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/med-22-12","article-title":"Good\u2019s syndrome and COVID-19: case report and literature review.","volume":"7","author":"Berzenji","year":"2023","journal-title":"Mediastinum"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/JLB.5COVA0620-370RR","article-title":"B cell analysis in SARS-CoV-2 versus malaria: increased frequencies of plasmablasts and atypical memory B cells in COVID-19.","volume":"109","author":"Wildner","year":"2021","journal-title":"J Leukoc Biol"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4269\/ajtmh.21-0883","article-title":"Recovery of memory B-cell subsets and persistence of antibodies in convalescent COVID-19 patients.","volume":"105","author":"Rajamanickam","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"107046","DOI":"10.1016\/j.ijid.2024.107046","article-title":"Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: a retrospective cohort study.","volume":"144","author":"Groning","year":"2024","journal-title":"Int J Infect Dis"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jiac.2024.01.008","article-title":"Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir\/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma.","volume":"30","author":"Maruki","year":"2024","journal-title":"J Infect Chemother"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"1399180","DOI":"10.3389\/fimmu.2024.1399180","article-title":"Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report.","volume":"15","author":"Billi","year":"2024","journal-title":"Front Immunol"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/cid\/ciad368","article-title":"Commercial immunoglobulin products contain neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 spike protein.","volume":"77","author":"Upasani","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"6212410","DOI":"10.1155\/2018\/6212410","article-title":"Aberrant peripheral immune function in a Good syndrome patient.","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/CM9.0000000000000774","article-title":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.","volume":"133","author":"Ling","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"596631","DOI":"10.3389\/fimmu.2020.596631","article-title":"Sharing CD4+ T cell loss: when COVID-19 and HIV collide on immune system.","volume":"11","author":"Peng","year":"2020","journal-title":"Front Immunol"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/jmv.26742","article-title":"Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity.","volume":"93","author":"Cizmecioglu","year":"2021","journal-title":"J Med Virol"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10495-021-01656-2","article-title":"Apoptosis induced by SARS-CoV-2: can we target it?","volume":"26","author":"Donia","year":"2021","journal-title":"Apoptosis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:01:15Z","timestamp":1779530475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":26,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046198","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}